Viewing Study NCT07188012

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-01-22 @ 7:47 PM
Study NCT ID: NCT07188012
Status: RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-08-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients
Sponsor: Shanghai Siponuoyin Biotechnology Co Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy (DMD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Duchenne Muscular Dystrophy View
None North Star Ambulatory Assessment View
None Dystrophin View
None Gene Therapy View
None Extracellular Vesicles View